# Metagenomi Therapeutics, Inc.: Form DEF 14A, filed Apr 28, 2025

- Company: [Metagenomi Therapeutics, Inc.](/companies/mgx.md) (CIK 1785279)
- Form: DEF 14A
- Filed: 2025-04-28
- Accepted by EDGAR: Apr 28, 2025, 16:01 ET
- Period: 2025-04-25
- Accession: 0000950170-25-059276
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1785279/000095017025059276/mgx-20250425.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785279/000095017025059276/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785279/000095017025059276/mgx-20250425.htm

Filed Apr 28, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-059276. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.